KESHA MENEZES: Open Payments
NPI 1891379582 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 12 payments from 10 companies in 2025. Trend: 2023 $84 · 2024 $156 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $92 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| Merz Pharmaceuticals, LLC | 1 | $31 |
| SK Life Science, Inc. | 1 | $28 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| ACADIA Pharmaceuticals Inc | 1 | $21 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
Products named: QULIPTA, Symbravo, PONVORY, Xeomin, CREXONT, NUPLAZID, ULTOMIRIS, Leqembi.
Industry payments across NY — which companies pay providers there.
